Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LSS | P48449 | 3/20 | 0.69 |
| ▸ | GBA1 | P04062 | 1/20 | 0.41 |
| ▸ | GPR183 | P32249 | 3/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7658217 | 0.96 | LSS (0.66) | LSSGBA1GPR183SMN1; SMN2KDM4E | |
| SCHEMBL8310420 | 0.88 | LSS (0.66) | LSSGBA1GPR183SMN1; SMN2MAPT | |
| SCHEMBL6969184 | 0.88 | LSS (0.54) | LSSGBA1GPR183MAPTLMNA | |
| SCHEMBL6980618 | 0.87 | LSS (0.65) | LSSGBA1GPR183SMN1; SMN2KDM4E | |
| SCHEMBL6977387 | 0.86 | LSS (0.76) | LSSGBA1GPR183SMN1; SMN2KDM4E | |
| SCHEMBL6981290 | 0.85 | LSS (0.67) | LSSGPR183SMN1; SMN2KDM4EMAPT | |
| SCHEMBL6978604 | 0.82 | LSS (0.71) | LSSGBA1SMN1; SMN2KDM4EMEN1 | |
| SCHEMBL6182258 | 0.82 | LSS (1.00) | LSSLMNA | |
| SCHEMBL6979382 | 0.81 | LSS (0.48) | LSSGBA1GPR183KDM4EMEN1 | |
| SCHEMBL6977537 | 0.80 | LSS (0.93) | LSSSMN1; SMN2KDM4EMAPTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0925286-B1 | SUBSTITUTED PYRIMIDINE DERIVATIVES AND THEIR PHARMACEUTICAL USE | ASTRAZENECA AB (SE) | 2003-01-02 | — | — | EP | disclosed |
| US-6093718-A | AN OXIDO-SQUALENE CYCLASE INHIBITOR, ANTICHOLESTEROL AGENT FOR INHIBITING CHOLESTEROL BIOSYNTHESIS AND LOWERING CHOLESTEROL LEVELS IN BLOOD PLASMA; TREATING HYPERCHOLESTEROLEMIA AND ATHEROSCLEROSIS | ZENECA LIMITED (GB) | 2000-07-25 | — | — | US | disclosed |
| EP-0925286-A1 | SUBSTITUTED PYRIMIDINE DERIVATIVES AND THEIR PHARMACEUTICAL USE | ZENECA LIMITED (GB) | 1999-06-30 | — | — | EP | disclosed |
| WO-1998006705-A1 | SUBSTITUTED PYRIMIDINE DERIVATIVES AND THEIR PHARMACEUTICAL USE | ZENECA LIMITED (GB) | 1998-02-19 | — | — | WO | disclosed |